Dawling S and Crome P. 1989. Clinical pharmacokinetics
considerations in the elderly. An update. Clin Pharma-
cokinet 17:236.
Eichler H-G and Müller M. 1998. Drug distribution. The
forgotten relative in clinical pharmacokinetics. Clin
Pharmaokinet 34:95.
Giovanetti S and Barsotti G. 1991. In defense of creati-
nine clearance. Nephron 59:11.
Gonzales FJ and Idle JR. 1994. Pharmacogenetic pheno-
typing and genotyping. Present status and future
potential. Clin Pharmacokinet 26:59.
Grasela TH Jr. 1995. Population approaches to pharma-
cokinetics and risk management. In Schumacher GE,
ed.
Therapeutic Drug Monitoring
. Appleton & Lange,
Norwalk.
Greenberger PA, Cranberg JA, Ganz MA, and Hubler
GL. 1991. A prospective evaluation of elevated serum
theophylline concentrations to determine if high
concentrations are predictable. Amer J Med 91:67.
Guttendorf RJ and Wedlund PJ. 1992. Genetic aspects of
drug disposition and therapeutics. J Clin Pharmacol
32:107.
Harris RZ, Benet LZ, and Schwartz JB. 1995. Gender
effects in pharmacokinetics and pharmacodynamics.
Drugs 50:222.
Hervé F, Urien S, Albengres E, Duché J-C, and Tille-
ment J-P. 1994. Drug binding in plasma. A summary
of recent trends in the study of drug and hormone
binding. Clin Pharmacokinet 26:44.
Johnson JA. 1997. Influence of race or ethnicity on
pharmacokinetics of drugs. J Pharm Sci 86:1328.
Kashuba ADM and Nafziger AN. 1998. Physiological
changes during the menstrual cycle and their effects
on the pharmacokinetics and pharmacodynamics of
drugs. Clin Pharmacokinet 34:203.
Kinirons MT and Crome P. 1997. Clinical pharmacoki-
netics considerations in the elderly. An update. Clin
Pharmacokinet 33:302.
Kumor KM. 1985. Therapeutic drug monitoring. In Noe
DA, ed.
The Logic of Laboratory Medicine.
Urban &
Schwarzenberg, Baltimore.
Lam YWF, Banerji S, Hatfield C, and Talbert RL. 1997.
Principles of drug administration in renal
insufficiency. Clin Pharmacokinet 32:30.
Lee EJD and Williams KM. 1990. Chirality. Clinical
pharmacokinetic and pharmacodynamic considera-
tions. Clin Pharmacokinet 18:339.
Levy G. 1998. Predicting effective drug concentrations
for individual patients. Determinants of pharmacody-
namic variability. Clin Pharmacokinet 34:323
Linder MW, Prough RA, and Valdes Jr R. 1997.
Pharmacogenetics: a laboratory tool for optimizing
therapeutic efficiency. Clin Chem 43:2.
Loebstein R, Lalkin A, and Koren G. 1997. Pharmacoki-
netic changes during pregnancy and their clinical
relevance. Clin Pharmacokinet 33:328.
Luke DR, Halstenson CE, Opsahl JA, and Matzke GR.
1990. Validity of creatinine clearance estimates in the
assessment of renal function. Clin Pharmacol Ther
48:503.
MacKichan JJ. 1992. Influence of protein binding and use
of unbound (free) drug concentrations. In Evans WE,
Schentag JJ, and Jusko WJ (eds).
Applied Pharma-
cokinetics: Principles of Therapeutic Drug
Monitoring.
3rd edition. Applied Therapeutics,
Vancouver WA.
Morgan DJ and McLean. 1995. Clinical pharmacokinetic
and pharmacodynamic considerations in patients with
liver disease. An update. Clin Pharmacokinet 29:370.
Murphy JE. 1995. Monitoring drug therapy. In Schuma-
cher GE, ed.
Therapeutic Drug Monitoring
. Appleton
& Lange, Norwalk.
Noe DA. 1997. Noncompartmental pharmacokinetic
analysis. In Grochow LB and Ames MM, eds.
A
Clinician’s Guide to the Pharmacokinetics and
Pharmacodynamics of Chemotherapy.
Williams &
Wilkins, Baltimore.
Richens A and Dunlop A. 1975. Serum-phenytoin levels
in management of epilepsy. Lancet ii:247.
Schwartz GJ, Braion LP, and Spitzer A. 1987. The use of
plasma creatinine concentration for estimating
glomerular filtration rate in infants, children, and
adolescents. Pediatric Clin NA 34:571.
Schwartz GJ, Haycock GB, Edelmann CM Jr, and Spitzer
A. 1976. A simple estimate of glomerular filtration
rate in children derived from body length and plasma
creatinine. Pediatrics 58:259.
Wagner JG. 1976. Linear pharmacokinetic equations
allowing direct calculation of many needed pharma-
cokinetic parameters from the coefficients and
exponents of polyexponential equations which have
been fitted to data. J Pharmacokinet Biopharm 4:443.
Williams L, Hill DP Jr, Davis JA, and Lowenthal DT.
1996. The influence of food on the absorption and
metabolism of drugs: an update. Eur J Drug Metab
Pharmacokinet 21:201.
Yukawa E. 1996. Optimisation of antiepileptic drug
therapy. Clin Pharmacokinet 31:120.
Zini R, Riant P, Barré J, and Tillement J-P. 1990.
Disease-induced variations in plasma protein levels.
Implications for drug dosage regimens. Clin Pharma-
cokinet 19: (Part I) 147, (Part II) 218.
Drug Therapy
12-18
